177Lu-XH02

N/A

Report date: 2025/11/20 16:04:08

NME

Base Information

Drug Name177Lu-XH02

Drug Alias Name[177Lu]Lu-XH02

ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAminopeptidase N modulatorsIntegrin alpha-V/beta-3 modulators

TargetsAminopeptidase NIntegrin alpha-V/beta-3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHexin (Suzhou) Pharmaceutical Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHexin (Suzhou) Pharmaceutical Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A